[1]
T. Srisuk, “PREVALENCE OF SGLT2 INHIBITOR AND GLP-1 RECEPTOR AGONIST PRESCRIPTIONS IN PATIENTS WITH COMORBID DIABETES AND CARDIOVASCULAR DISEASE IN RAJAVITHI HOSPITAL”, J ASEAN Fed Endocr Soc, vol. 38, no. S3, pp. 56–57, Nov. 2023.